ArticleMicrocirculation (New York, N.Y. : 1994)2025
Microvascular Consequences of Methemoglobin Compared to Reduced Hemoglobin in the Microcirculation.
Article in Microcirculation (New York, N.Y. : 1994), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesThe development of hemoglobin-based oxygen carriers (HBOCs) offers a promising alternative to traditional blood transfusions, addressing critical limitations such as the need for cold storage, blood type matching, and a short ex vivo shelf life. HBOCs mimic the oxygen-carrying function of red blood cells without the risk of transfusion-related complications. However, hemoglobin is prone to oxidation when freely circulating in the vasculature, resulting in methemoglobin formation. In this oxidized state, Hb does not transport oxygen, scavenges less nitric oxide, but it is more toxic. As continued research tries to develop effective HBOCs for use in emergency medicine, there needs to be an understanding of the microvascular and toxicological effects of the reduced and oxidized forms of Hb. MATERIALS AND
methodsThe study involved Golden Syrian Hamsters instrumented with a dorsal skin window chamber model to observe the acute effects resulting from a hypervolemic infusion (10% of the animal's blood volume) of human Hb [HbFe
resultsMean arterial pressure (MAP) and heart rate (HR) were both altered; animals infused with hHb saw a significant increase in MAP and a decrease in HR, while animals infused with met-hHb saw a significant decrease in MAP and a decrease in HR. Infusion of hHb induced vasoconstriction and hypertension. However, infusion of met-hHb resulted in increased microvascular diameters compared to baseline, but a reduction in functional capillary density compared to baseline, alongside significant increases in inflammation, specifically in systemic and cardiac markers.
conclusionThis study illuminates the complex impact of Hb oxidation on microvascular function and inflammation, pivotal to understanding the safety and efficacy of HBOC formulations. Future research should focus on strategies to regulate Hb oxidation to enhance therapeutic benefit and minimize detrimental effects in emergency medicine settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.